Page last updated: 2024-10-22

antipyrine and Experimental Pneumococcal Meningitis

antipyrine has been researched along with Experimental Pneumococcal Meningitis in 1 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Z1
Ma, QQ1
Yan, Y1
Xu, FD1
Zhang, XY1
Zhou, WQ1
Feng, ZC1

Other Studies

1 other study available for antipyrine and Experimental Pneumococcal Meningitis

ArticleYear
Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:10

    Topics: Animals; Antipyrine; Edaravone; HMGB1 Protein; Meningitis, Pneumococcal; Mice; Mice, Inbred C57BL; N

2016